Mining Symbionts of a Spider‐Transmitted Fungus Illuminates Uncharted Biosynthetic Pathways to Cytotoxic Benzolactones
A spider‐transmitted fungus (Rhizopus microsporus) that was isolated from necrotic human tissue was found to harbor endofungal bacteria (Burkholderia sp.). Metabolic profiling of the symbionts revealed a complex of cytotoxic agents (necroximes). Their structures were characterized as oxime‐substitut...
Gespeichert in:
Veröffentlicht in: | Angewandte Chemie 2020-05, Vol.132 (20), p.7840-7845 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A spider‐transmitted fungus (Rhizopus microsporus) that was isolated from necrotic human tissue was found to harbor endofungal bacteria (Burkholderia sp.). Metabolic profiling of the symbionts revealed a complex of cytotoxic agents (necroximes). Their structures were characterized as oxime‐substituted benzolactone enamides with a peptidic side chain. The potently cytotoxic necroximes are also formed in symbiosis with the fungal host and could have contributed to the necrosis. Genome sequencing and computational analyses revealed a novel modular PKS/NRPS assembly line equipped with several non‐canonical domains. Based on gene‐deletion mutants, we propose a biosynthetic model for bacterial benzolactones. We identified specific traits that serve as genetic handles to find related salicylate macrolide pathways (lobatamide, oximidine, apicularen) in various other bacterial genera. Knowledge of the biosynthetic pathway enables biosynthetic engineering and genome‐mining approaches.
Spinnensinn: Der Pilz Rhizopus microsporus, isoliert aus nekrotischem Gewebe nach einem Spinnenbiss, enthält Bakterien (Burkholderia sp.), die einen Komplex hoch zytotoxischer Verbindungen (Nekroxime) produzieren. Analyse der PKS/NRPS‐Hybrid‐Assemblierungslinie und Genome‐Mining offenbarten die molekulare Grundlage der Biosynthese von V‐ATPase‐inhibierenden Tumortherapeutika verschiedenen biologischen Ursprungs. |
---|---|
ISSN: | 0044-8249 1521-3757 |
DOI: | 10.1002/ange.201916007 |